SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Troutbum who wrote (3873)6/11/2001 11:33:01 AM
From: Mike M  Read Replies (1) | Respond to of 5582
 
Spin is such an overused commodity.

It's not very liquid unless you count the drool on Hank's chin.



To: Troutbum who wrote (3873)7/19/2001 10:30:21 AM
From: Mike M  Respond to of 5582
 
I suspect that this news is the harbinger to today's announcement that the vote for sale of the gum business is favorable. Moreover, I doubt that it is a coincidence that Mr Johnson is another former employee of J&J now with GUMM.

siliconinvestor.com

Gum Tech International, Inc. Announces New President
PHOENIX, Jul 18, 2001 /PRNewswire via COMTEX/ -- Gum Tech International, Inc., (Nasdaq: GUMM chart, msgs) announced today the addition of Carl J. Johnson as President of the Company and a member of the Board of Directors.

Mr. Johnson's professional experience spans twenty years in the product development, marketing, and sales arenas with several large pharmaceutical and consumer goods companies. Most recently, Mr. Johnson was Vice President, Commercial Development with Perrigo Company, a public company and leading manufacturer of OTC pharmaceutical and nutritional products for the store brand market. In that capacity he was responsible for the procurement of new products and technologies and contract manufacturing services with emphasis on Abbreviated New Drug Applications (ANDA) products. Mr. Johnson's experience also includes over 15 years with Johnson & Johnson, where he held a number of positions of increasing responsibility in marketing and sales, including responsibility for the national launch of the Acuvue(R) disposable contact lenses. Mr. Johnson also provided marketing leadership for a special Johnson & Johnson team that was selected to re-engineer sales, administrative and operational functions.

Mr. Johnson has also consulted with a number of companies in the areas of business development, sales and business management through his consulting firm, Johnson Marketing Services and gained advertising management experience while working at Compton Advertising in New York on the Procter & Gamble account.

Mr. Edward Faber, Chairman of the Board of Gum Tech, stated "Carl's experience and background is a perfect match for Gum Tech and will bring benefit to the Company. His background in strategic business relationships and product development in the pharmaceutical and consumer goods industries will be invaluable as we move beyond the scheduled sale of our gum manufacturing assets to Wrigley's."

Mr. Johnson succeeds Gary Kehoe as President of the Corporation. Mr. Kehoe will become Interim Chief Executive Officer of the Company pending the scheduled July 20, 2001 completion of the Wrigley transaction.

Gum Tech International, Inc. is an innovative nutrient and drug delivery technology company engaged in the development, manufacture and marketing of delivery systems for bioactive compounds. Gum Tech is the majority owner of Gel Tech LLC that markets Zicam(TM) Cold Remedy, a patented, revolutionary homeopathic remedy, and Zicam(TM) Allergy Relief, a homeopathic remedy designed to provide relief to allergy sufferers. In a study published in the October 2000 issue of the ENT -- Ear, Nose & Throat Journal, Zicam(TM) Cold Remedy was shown to reduce the duration of the common cold by an average of 75% when taken at the onset of symptoms.

For additional information, please contact Lynn Romero, Manager of Investor Relations, 602-252-1617, ext. 320, lromero@gum-tech.com. Gum Tech is located at 246 East Watkins Street, Phoenix, Arizona 85004.